MedTrace Logo

Action Plan to Enhance Self-management and Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00879281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2011-02-24

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to evaluate the hypothesis that the 'written' action plan, a self-management tool developed by the project group, enhances early detection and prompt action measures and consequently isbeneficial in exacerbation outcome (i.e., health status recovery time).

Conditions

Interventions

BEHAVIORAL

Action plan

Individualized "written" Action Plan to enhance self-management and early detection of an exacerbation.

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Jaap C.A. Trappenburg, MSc · University Medical Center Utrecht, The Netherlands

  • Gerdien D. de Weert - van Oene, PhD · University Medical Center Utrecht, The Netherlands

  • Evelyn M. Monninkhof, PhD · University Medical Center Utrecht, The Netherlands

  • Thierry Troosters, PhD · KU Leuven

  • Jean Bourbeau, PhD · McGill University, Montreal Chest Institute, Canada

  • Theo J.M. Verheij, PhD · University Medical Center Utrecht, The Netherlands

  • Jan-Willem J. Lammers, PhD · University Medical Center Utrecht, The Netherlands

  • Guus J.P. Schrijvers, PhD · University Medical Center Utrecht, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-09-30
Completion
2010-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00879281 on ClinicalTrials.gov